Lyell Immunopharma LYEL Q1 2026 Earnings Narrower Loss Beats Estimates as Biotech Advances Pipeline WHG Q1 2026 Earnings Earnings Per Share of 031 Amid Mixed Market Conditions DAWN Q4 2025 Earnings WiderThanExpected Loss As PreRevenue Biotech Advances Pipeline Oxford Lane Capital Corp Preferred Stock Shares 600 Series 2029 OXLCO Q4 2025 Earnings EPS Misses Estimates Despite Solid Operating Results WIMI Q4 2020 Earnings EPS Misses Estimates Amidst Market Decline Pinnacle Financial Partners PNFP Edges Lower as Shares Consolidate Between Support and Resistance Foremost Clean Energy FMST Pushes Higher Testing Key Resistance Zone Sensient Technologies Holds Steady Near Support Amid Modest Gains Invesco Quality Municipal Income Trust IQI Edges Higher as Bond Market Sentiment Improves Amicus Therapeutics FOLD Q4 2025 Earnings EPS Falls Far Short of Estimates Amid Thin Operational Detail